Tezepelumab-Ekko
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Depemokimab (Exdensur) for severe eosinophilic asthma.
Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026
Safety of biologics for the treatment of asthma in children and adolescents: a systematic review.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: December 02, 2024
The Effect of Thymic Stromal Lymphopoietin on Reflux Esophagitis.
Journal: Journal of physiological investigation
Published: June 24, 2024
The new biologic drugs: Which children with asthma should get what?
Journal: Pediatric pulmonology
Published: March 23, 2024
Tezepelumab (Tezspire®) : new biological treatment of severe asthma
Journal: Revue medicale de Liege
Published: January 15, 2024
Mechanism of action of tezepelumab (TEZSPIRE®) and clinical trial results in asthma
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: January 03, 2024
Severe Asthmatic Responses: The Impact of TSLP.
Journal: International journal of molecular sciences
Published: March 08, 2023
Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study.
Journal: Frontiers in immunology
Published: September 21, 2022
Tezepelumab in the Treatment of Uncontrolled Severe Asthma.
Journal: The Annals of pharmacotherapy
Published: May 10, 2022
Tezspire Approved for Severe Asthma.
Journal: The American journal of nursing
Published: April 21, 2022
Last Updated: 04/28/2026